Business
BioSpectrum Asia
Scientists In New Zealand Identify Drug That Could Extend Lifespan
The age-old quest for immortality has taken a step forward with the results of a New Zealand study recently published by the researchers at the University of Auckland.
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
How Plausible Is Ending TB Scourge?
Despite countries making bold commitments to end TB by 2030, in the Sustainable Development Goals, the WHO End TB Strategy and the 2018 political declaration on the fight against TB, the epidemic shows no sign of slowing down.
10 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
Can Med Tourism Industry Hit Goldmine With Robot-Assisted Surgery?
The quality of Healthcare is projected to become enhanced in the future, aided by new innovations in technology.
10+ min |
BioSpectrum Asia March 2023
BioSpectrum Asia
Sciex expands protein characterisation capabilities
Sciex, a US-based leader in life science analytical technologies, has announced the launch of the Fast Glycan Labeling and Analysis kit for quantitative glycan analysis and an update for Biologics Explorer software to enhance critical protein therapeutic analysis workflows.
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
Korea designs smart contact lens for diagnosing and treating glaucoma
A research team at Pohang University of Science and Technology (POSTECH) in South Korea has developed a smart contact lens by combining an intraocular pressure (IOP) sensor and a flexible drug delivery system to manage IOP measurement and medication administration in glaucoma patients.
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
World Health Organisation releases new Global Breast Cancer Initiative Framework
The World Health Organisation (WHO) has released a new Global Breast Cancer Initiative Framework providing a roadmap to attain the targets to save 2.5 million lives from breast cancer by 2040.
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
CEPI collaborates to advance tools for Sudan ebolavirus vaccine research
The Coalition for Epidemic Preparedness Innovations (CEPI) is supporting the development of an international antibody standard against Sudan ebolavirus (SUDV)
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
Global Fund provides $867M in additional funding for pandemic preparedness and response
Since December 2022, the Global Fund has awarded $547 million in additional funding to 40 countries through its COVID-19 Response Mechanism (C19RM) and has now initiated the process to award a further $320 million, making a total of approximately $867 million.
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
The New Pandemic Of Layoffs
Employees across various sectors have been hit hard due to various restructuring measures leading to layoffs.
6 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
Formosa Pharma inks agreement with Eyenovia for new ophthalmic therapies
Taiwan-based Formosa Pharmaceuticals has entered into a collaboration agreement with US-based Eyenovia, for the development of novel ophthalmic therapeutics.
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
Eli Lilly ensures patient access to high-quality affordable insulin in Bangladesh
American pharmaceutical firm Eli Lilly and Company will supply its active pharmaceutical ingredient (API) for human insulin at a reduced price to International Agencies (Bangladesh) Ltd.
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
Daewoong inks $336M deal with CS Pharma for Idiopathic Pulmonary Fibrosis treatment
South Korea’s Daewoong Pharmaceutical has secured an exclusive licensing agreement with CS Pharmaceuticals,
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
Gavi and India join hands to protect children with life-saving vaccines
Gavi, the Vaccine Alliance, and the Government of India have established a new three-year partnership that aims to reach millions of children in the country with life-saving vaccines.
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
China approves AI software to assess symptoms of Parkinson's disease
Nervtex's MoDAS artificial intelligence (AI) system has become the first video-based, AI-powered medical device to win regulatory approval for assessing motor symptoms in Parkinson's disease and other movement disorders, according to a company press release.
1 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
APAC Fem Tech Space Gains Momentum
Do you know what takes the blame for a woman’s bad health? Oestrogen, as it is the hormone that plays a central role in women’s health.
10+ min |
BioSpectrum Asia March 2023
BioSpectrum Asia
Can India Eliminate TB by 2025?
Tuberculosis (TB) is a severe public health issue in India, accounting for a quarter of the global TB burden.
5 min |
BioSpectrum Asia March 2023
BioSpectrum Asia
How Imaging Tech And Liquid Biopsy Will Play Pivotal Role In Cancer Care
A core tenet of precision medicine is to simplify the delivery of the right treatment to the right patient at the right dose and at the right time.
5 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Sartorius & RoosterBio to advance downstream purification for exosomes manufacturing
Germany-headquartered Sartorius has extended a strategic collaboration partnership agreement with US-based RoosterBio to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Qiagen launches EZ2 Connect MDx platform for automated sample processing in diagnostic labs
Qiagen has announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the in vitro diagnostic (IVD) platform for automated sample processing available for wide scale use 18 months after being made available for research.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Shimadzu opens door to biomolecular imaging with new compact MALDI-TOF solution
Japan-headquartered Shimadzu Corporation has announced the release of the world’s smallest MALDI-TOF imaging solution, available as an option on the successful benchtop MALDI-TOF mass spectrometry series: the MALDI-8020 for positive ion analysis and the MALDI-8030, which features a dual-polarity ion source.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Thermo Fisher unveils CE-IVD marked assay to detect treatment-resistant HIV-1 strains
Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems TaqPath Seq HIV1 Genotyping Kit, a Sanger sequencing-based assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that may resist common antiretroviral therapeutics.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Study in NZ, Australia set to change treatment of children with acute respiratory problems
A world-first Australian and New Zealand (NZ) study is set to change how clinicians treat children with acute respiratory problems, improving best care and potentially saving millions of healthcare dollars, particularly in remote, rural and indigenous communities.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Korea provides new equation to US FDA for improving drug interaction prediction
The US Food and Drug Administration (FDA) recommends indirect evaluation of drug interactions using a formula suggested in their guidance first published in 1997, revised in January of 2020, in order to evaluate drug interactions and minimise side effects of having to use more than one type of drugs at once.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Singapore demonstrates quantum recoil, paving way for precise X-ray imaging in healthcare
For the first time since it was proposed over 80 years ago, scientists from Nanyang Technological University, Singapore (NTU Singapore) have demonstrated the phenomenon of \"quantum recoil\", which describes how the particle nature of light has a major impact on electrons moving through materials.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Australia turns back the clock on damaged heart tissue
An international team of researchers, led by University of Sydney in Australia, has developed a method to reverse the loss of elasticity of damaged heart tissue following heart attacks.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Former FDA medical device officer joins Pulnovo Medical's scientific advisory board
China-based Pulnovo Medical has announced the appointment of Dr Mingdong Zhang to the company’s Scientific Advisory Board (SAB).
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
SK Bioscience accelerates global growth strategy by picking talent from Big Pharma
South Korea-based SK bioscience has announced that Richard Kensinger, PhD, former Director and Head of Drug Substance Process Development in SanofiPasteur and former Executive Director of Process Development and Protein Sciences at Affinivax Inc. has joined in ‘SK bioscience USA Inc.’ as Vice President of R&D Project Management. Dr Kensinger is an expert who has been dedicated to biopharmaceutical R&D, working at global companies for more than 20 years.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Dr David John Jeans steps in as HistoIndex's Non-Executive Chairman
Rockwell Automation, dedicated to industrial automation and digital transformation across sectors including pharma and healthcare, has appointed Mariya Prempeh as country manager for Singapore, effective immediately.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Rockwell appoints Mariya Prempeh Singapore Country Manager
Rockwell Automation, dedicated to industrial automation and digital transformation across sectors including pharma and healthcare, has appointed Mariya Prempeh as country manager for Singapore, effective immediately.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Asieris Pharma appoints Dr Linda Wu as Chief Development Officer
Asieris Pharmaceuticals, a China-based biopharma company specialising in discovering, developing and commercialising innovative drugs for the treatment of genitourinary tumours and other related diseases, has announced that Linda Wu, PhD will join Asieris as Chief Development Officer.
1 min |